A fé, o fuzil e o altar: como o “governador de Deus” transformou o louvor em política de extermínio e alinhou o Rio à doutrina de guerra de Donald Trump ...
In a bid to cater to the growing demand for health-focused snacks, Novos has introduced the Novos Bar, touted as the first functional longevity bar designed to promote healthy ageing. This new product ...
As contas do FC Porto relativas a 2024/25, tanto individuais como consolidadas, foram aprovadas esta terça-feira, em ...
Hosted on MSN
Descubra Novos Estilos Ousados - MSN
Atriz Isabelle Tate morre aos 23 anos após gravar episódio de nova série Por que anúncio envolvendo Reagan fez Trump suspender negociação de tarifa com o Canadá Europeus reagem a feito histórico de ...
Novo Nordisk NOVO.B2.49%increase; green up pointing triangle said it would take over a drug under development to treat rare blood and kidney disorders from Nasdaq-listed biopharmaceutical firm Omeros ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A troubled Indiana ...
Novo Nordisk is drawing divided views from Wall Street analysts. Some may be disappointed by the loss of market share to Eli Lilly. Three events could turn sentiment positive in the coming months. The ...
Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...
Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...
Novo Nordisk is acquiring Akero Therapeutics for up to $5.2bn, aiming to diversify beyond semaglutide and strengthen its position in MASH and cirrhosis. The deal brings Akero's EFX, a promising FGF21 ...
Novo Nordisk A/S agreed to buy Akero Therapeutics Inc. for as much as $5.2 billion to expand its portfolio in a type of liver disease that’s linked to obesity. Novo will pay $54 a share in cash, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback